Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Nov;88(11):1638-44.
doi: 10.2105/ajph.88.11.1638.

Costs and cost-effectiveness of a universal, school-based hepatitis B vaccination program

M Krahn  1 , R Guasparini, M Sherman, A S Detsky
Affiliations

Costs and cost-effectiveness of a universal, school-based hepatitis B vaccination program

M Krahn et al. Am J Public Health. 1998 Nov.

Abstract

Objectives: This study evaluated the costs and cost-effectiveness of a school-based grade 6 universal vaccination program against hepatitis B.

Methods: We performed a descriptive cost study and cost-effectiveness analysis of British Columbia's vaccination program for 1994 and 1995. Since 1992, public health nurses have administered hepatitis B vaccine to grade 6 students in schools. We measured costs of vaccine, vaccine administration, and net program costs and used a validated Markov model to calculate the cost-effectiveness of the program.

Results: Vaccinating each student cost $44, $24 of which was the cost of vaccine administration. The net cost was $9 per person; considering productivity costs, net savings were $75 per person. Marginal cost per life year gained was $2100. Universal adolescent vaccination is also economically attractive in the United States but less attractive in regions with incidence rates below 3 cases per 100,000 per year.

Conclusions: Hepatitis B vaccine can be delivered in North American schools at a reasonable cost. Adolescent vaccination is economically attractive in North American regions of high and average incidence rates. Our analysis supports vaccination in adolescents who remain at risk for hepatitis B virus infection.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Bull World Health Organ. 1980;58(4):621-8 - PubMed
    1. Clin Infect Dis. 1993 May;16(5):709-13 - PubMed
    1. JAMA. 1988 Jan 15;259(3):365-9 - PubMed
    1. Cancer. 1988 May 15;61(10):1942-56 - PubMed
    1. Am J Med. 1989 Sep 4;87(3A):5S-10S - PubMed